Unconventional T cells - New players in antifungal immunity

Clin Immunol. 2021 Jun:227:108734. doi: 10.1016/j.clim.2021.108734. Epub 2021 Apr 22.

Abstract

Life-threatening invasive fungal diseases (IFD) are increasing in incidence, especially in immunocompromised patients and successful resolution of IFD requires a variety of different immune cells. With the limited repertoire of available antifungal drugs there is a need for more effective therapeutic strategies. This review interrogates the evidence on the human immune response to the main pathogens driving IFD, with a focus on the role of unconventional lymphocytes e.g. natural killer (NK) cells, gamma/delta (γδ) T cells, mucosal associated invariant T (MAIT) cells, invariant natural killer T (iNKT) cells and innate lymphoid cells (ILC). Recent discoveries and new insights into the roles of these novel lymphocyte groups in antifungal immunity will be discussed, and we will explore how an improved understanding of antifungal action by lymphocytes can inform efforts to improve antifungal treatment options.

Keywords: Gamma delta T cells; Immunotherapy; Innate lymphoid cells; Invariant natural killer T cells; Invasive fungal disease; Mucosa associated invariant T cells; Natural killer cells; Unconventional lymphocytes.

Publication types

  • Review

MeSH terms

  • Antifungal Agents / therapeutic use
  • Humans
  • Immunity, Innate / immunology
  • Intraepithelial Lymphocytes / immunology*
  • Invasive Fungal Infections / drug therapy
  • Invasive Fungal Infections / immunology*
  • Killer Cells, Natural / immunology*
  • Lymphocyte Subsets / immunology
  • Mucosal-Associated Invariant T Cells / immunology*
  • Natural Killer T-Cells / immunology*
  • T-Lymphocyte Subsets / immunology

Substances

  • Antifungal Agents